Literature DB >> 16080592

Community-based study of cataracts among type 2 diabetics in Kinmen.

Tao-Hsin Tung1, Jorn-Hon Liu, Fenq-Lih Lee, Shih-Jen Chen, Ching-Yao Tsai, Pesus Chou.   

Abstract

The purpose of this study was to assess the prevalence and risk factors of each type of cataract among type 2 diabetics in Kinmen, Taiwan. There were 971 type 2 diabetics ascertained from a community-based mass screening between 1991 and 1993. In 1999, a total of 578 (59.5%) patients with type 2 diabetes were examined with an eye screening performed by two senior ophthalmologists using a 45-degree thin slit-lamp biomicroscopy and ophthalmoscopy to examine the lens after dilating the pupils. The overall prevalence, including subjects with or without surgery, was 31.0% (179/578, 95% CI: 27.3-34.7%), and had a statistically significant difference for gender (chi2 = 8.78, p = 0.003) and age (chi2-trend = 11.89, p < 0.0001). Based on multiple logistic regression, the significant risk factors of all types of cataracts were age (OR = 1.16, 95% CI: 1.12-1.20), lower diastolic blood pressure (DBP) at baseline (OR = 0.47, 95% CI: 0.25-0.88), and higher triglyceride at baseline (OR = 2.19, 95% CI: 1.07-4.45). In conclusion, our results found that in addition to age, lower DBP and higher triglyceride at baseline may increase the risk of prevalent cataracts in type 2 diabetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080592     DOI: 10.1007/s10654-004-7537-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Prevalence of lens opacity in Chinese residents of Singapore: the tanjong pagar survey.

Authors:  Steve K L Seah; Tien Yin Wong; Paul J Foster; Tze Pin Ng; Gordon J Johnson
Journal:  Ophthalmology       Date:  2002-11       Impact factor: 12.079

2.  Metabolic and social risk factors in a cataractous population. A case-control study.

Authors:  S Miglior; F Bergamini; L Migliavacca; P Marighi; N Orzalesi
Journal:  Dev Ophthalmol       Date:  1989

3.  Selected diseases and risk of cataract in women. A case-control study from northern Italy.

Authors:  A Tavani; E Negri; C La Vecchia
Journal:  Ann Epidemiol       Date:  1995-05       Impact factor: 3.797

4.  Risk factors for nuclear opalescence in a longitudinal study. LSC Group. Longitudinal Study of Cataract.

Authors:  M C Leske; L T Chylack; Q He; S Y Wu; E Schoenfeld; J Friend; J Wolfe
Journal:  Am J Epidemiol       Date:  1998-01-01       Impact factor: 4.897

5.  Prevalence of cataracts in a population-based study of persons with diabetes mellitus.

Authors:  B E Klein; R Klein; S E Moss
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

6.  The VF-14. An index of functional impairment in patients with cataract.

Authors:  E P Steinberg; J M Tielsch; O D Schein; J C Javitt; P Sharkey; S D Cassard; M W Legro; M Diener-West; E B Bass; A M Damiano
Journal:  Arch Ophthalmol       Date:  1994-05

7.  Identification of metabolic risk factors for posterior subcapsular cataract.

Authors:  C E Jahn; M Janke; H Winowski; K von Bergmann; O Leiss; O Hockwin
Journal:  Ophthalmic Res       Date:  1986       Impact factor: 2.892

8.  A population survey on the prevalence of diabetes in Kin-Hu, Kinmen.

Authors:  P Chou; M J Liao; H S Kuo; K J Hsiao; S T Tsai
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

9.  Senile lens changes and diabetes in two population studies.

Authors:  F Ederer; R Hiller; H R Taylor
Journal:  Am J Ophthalmol       Date:  1981-03       Impact factor: 5.258

10.  Hypertension and lens opacities from the Beaver Dam Eye Study.

Authors:  B E Klein; R Klein; S C Jensen; K L Linton
Journal:  Am J Ophthalmol       Date:  1995-05       Impact factor: 5.258

View more
  1 in total

1.  Assessment of cataract forming effect of diabetes in young adults by lens densitometer.

Authors:  Neslihan Bayraktar Bilen; Murat Sinan Sarıcaoğlu
Journal:  Int Ophthalmol       Date:  2020-10-28       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.